Clinical Trial

Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework

Name: Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework — clinical trial record (NCT07171814)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TTE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of Honghua Xiaoyao tablets in the treatment of premenstrual syndrome, and the results were further analyzed and evaluated by target trial simulation (TTE) framework.

Trial Details

NCT Number	NCT07171814
Lead Sponsor	Lianxin Wang Collaborators: Chaoyangmen Community Health Service Center of Dongcheng District in Beijing, Hepingli Community Health Service Center,Dongcheng District,Beijing
Conditions	Premenstrual Syndrome
Enrollment	266 participants
Start Date	2025-09-30
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-15